This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oberwill, CH (1999)
- Oberwil, CH (2001)
Company Filing History:
Years Active: 1999-2001
Title: The Innovations of Paul Pfaeffli
Introduction
Paul Pfaeffli is a notable inventor based in Oberwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with somatostatin receptors. With a total of 2 patents to his name, Pfaeffli's work has the potential to impact medical treatments significantly.
Latest Patents
Among his latest patents are innovative compounds, including Ergoline derivatives and their use as somatostatin receptor antagonists. This invention provides compounds of formula I that could lead to advancements in therapeutic applications. Additionally, he has developed Benzoquinoline derivatives, which further showcase his inventive capabilities.
Career Highlights
Paul Pfaeffli is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Peter Neumann and Robert Swoboda. Their collective expertise has fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical compounds.
Conclusion
Paul Pfaeffli's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile